The geriatric depression scale is a screening tool that can help identify depression in older adults. Learn about the ...

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced the publication of a ...

Myriad Genetics' GeneSight test outperforms treatment-as-usual in major depression, raising hopes for broader adoption and renewed stock momentum.

Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today ...

Fitzpatrick is a behavioral health care quality manager at Epic Systems. Engel, M.D., Ph.D., is a recent graduate of Harvard Medical School and a first-year psychiatry resident at Stanford. Boyd, M.D.

A world-first study has shown that it is possible to determine who is likely to get depression in late-life based on a "genetic score." The longitudinal study of more than 12,000 people over 70 paves ...

Detailed price information for Myriad Genetics Inc (MYGN-Q) from The Globe and Mail including charting and trades.

Introduction Atrial fibrillation (AF) is the most common cardiac arrhythmia, significantly affecting patients’ quality of life (QoL) and increasing the risk of complications such as heart failure, ...

A new study shows an association between at least 10 weeks of following a well-formulated ketogenic diet and a roughly 70% ...

Introduction Poststroke depression affects approximately 30% of stroke survivors and is linked to worse functional outcomes, cognitive decline, reduced quality of life and increased mortality. While ...

A 57-year-old homemaker, Ms. A, began occasionally losing items or struggling to recall people’s names a year ago. She ...